Primary pulmonary osteosarcoma: Case report and molecular analysis

Cancer

Volumn 91, Issue 4, 2001, Pages 779-784

  Chapman, Andrea D ^a   Pritchard, Stuart C ^b   Yap, Wan Wan ^a,b   Rooney, Patrick H ^b   Cockburn, John S ^c   Hutcheon, Andrew W ^c   Nicolson, Marianne C ^c   Kerr, Keith M ^a   McLeod, Howard L ^b,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BCL 2; Comparative genome hybridization; Cyclin D1; Primary pulmonary osteosarcoma

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIN D; PROTEIN BCL 2;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SARCOMA; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035865001     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010215)91:4<779::aid-cncr1064>3.0.co;2-j     Document Type: Article

References (28)

1. Primary osteosarcoma of the lung: Report of two cases and review of the literature
2. Rare pulmonary neoplasms
3. Comparative genomic hybridisation and chromosomal instability in solid tumors
4. Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors
5. A review of 40 patients with extraskeletal osteosarcoma
6. Extraosseous osteogenic sarcoma. A review of 48 patients
7. Sarcomas of the lung
8. Extraskeletal osteosarcoma of the lungs
9. Extraosseous osteosarcoma of the lungs
10. Primary extraskeletal osteosarcoma: Experience with chemotherapy
11. Extraskeletal osteosarcomas - A clinicopathologic study of 25 cases
12. Prognostic markers in osteosarcoma: An analysis of BCL-2, p53, c-erbB, Ki-67 and HSP27 by immunohistochemistry
13. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone
14. Mutation spectrum of the retinablastoma gene in osteosarcomas
15. 1 phase regulation in osteosarcoma
16. Prognostic significance of cyclin expression in human osteosarcoma
17. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas
18. C-myc and c-fos in human osteosarcoma: Prognostic value of mRNA and protein expression
19. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
20. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
21. P53 and MDM2 alterations in osteosarcoma. Correlation with clinicopathologic features and proliferative rate
22. P53 gene abnormalities in osteosarcoma
23. Cytogenetic findings in osteosarcoma specimens and a review of the literature
24. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization
25. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas
26. Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas
27. Synergistic cytotoxicity of BCL-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines
28. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line